PRODUCT LITERATURE

Efectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial

---

Although the number of antihyperglycemic agents has expanded signifcantly, sulfonylureas (in particular gliclazide) remain an important option because of a variety of patient and health system factors. The large, real
world, observational, and international EASYDia trial evaluated the efectiveness of gliclazide modifed release (MR)
60 mg in individuals with type 2 diabetes with a broad range of diabetes history, body mass index (BMI) and background antihyperglycemic treatment

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Fonylin MR

Specific Detail Info

Diabetol Metab Syndr (2018) 10:30

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment